Charles River Laboratories | Bruttoergebnis Vom Umsatz



Gross Profit On Sales Veränderung Datum
Agilent USD 866M 33M 2025-04
Align Technology USD 708.12M 28.01M 2025-06
Bio-Rad Laboratories USD 345.3M 34.7M 2025-06
Bruker USD 357.9M 33.3M 2025-06
Cardinal Health USD 2.12B 182M 2025-03
Charles River Laboratories USD 291.68M 48.42M 2025-06
Cigna USD 6.16B 445M 2025-06
CVS Health USD 13.59B 803M 2025-06
Danaher USD 3.52B 3M 2025-06
Dentsply International USD 490M 24M 2025-06
Elevance Health 13.07B 509M 2025-06
Galapagos EUR 61.25M 98.68M 2025-03
Hologic USD 576.6M 15.9M 2025-06
Humana 4.82B 754M 2025-06
Illumina USD 695M 12M 2025-06
Incyte USD 1.14B 151.67M 2025-06
IQVIA Holdings USD 1.05B 251M 2025-06
Laboratory Of America USD 1.05B 98.2M 2025-06
Lonza CHF 1.04B 72M 2024-12
McKesson USD 3.28B 100M 2025-06
Merck EUR 3.03B 118M 2025-06
Mettler Toledo International USD 579.88M 54M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Pfizer USD 11.12B 987M 2025-03
Quest Diagnostics USD 904M 35M 2025-06
Revvity USD 392.56M 17.01M 2025-06
Thermo Fisher Scientific USD 4.05B 260M 2025-06
United Therapeutics USD 711M 9.1M 2025-06
UnitedHealth 98.6B 74.82B 2025-06
Walgreens Boots Alliance USD 6.51B 428M 2025-05
Waters USD 438.02M 53.06M 2025-06
West Pharmaceutical Services USD 273.9M 42M 2025-06


Charles River Laboratories Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.